Octreotide

gastrin ; Homo sapiens







33 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28609362 Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors. 2017 Jul 1
2 28626400 Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma). 2017 May-Aug 1
3 27785232 Hormonal Effects on Nodular GAVE. 2013 Apr 1
4 20074162 Treatment of type I gastric neuroendocrine tumors with somatostatin analogs. 2010 Mar 1
5 20686291 Long-term suppressive effect of octreotide on progression of metastatic gastrinoma with multiple endocrine neoplasia type 1: seven-year follow up. 2010 2
6 14564638 Octreotide in control of multiple liver metastases from gastrinoma. 2003 1
7 11932320 A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. 2002 Apr 1
8 12063865 [Octreotide therapy in multiple endocrine neoplasia type-1]. 2002 May 12 1
9 11277423 Immunohistochemical assessment of an asymptomatic glucagonoma in a patient with hypergastrinemia and marked antral angiodysplasia. 2001 Mar 1
10 11373059 Stimulated gastrointestinal hormone release and gallbladder contraction during continuous jejunal feeding in patients with pancreatic pseudocyst is inhibited by octreotide. 2000 Dec 1
11 10695215 Octreotide treatment for a malignant islet cell tumor with variable hormone secretion: case report. 1999 Dec 1
12 9516403 Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor. 1998 Apr 1
13 9820614 Effect of the somatostatin analog octreotide on gastric mucosal function and histology during 3 months of preoperative treatment in patients with acromegaly. 1998 Oct 2
14 8678447 Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours. 1996 Mar 1
15 8813459 Somatostatin receptor regulation of gastric carcinoid tumours. 1996 2
16 7518781 Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. 1994 Aug 1
17 7911441 Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. 1994 1
18 7985099 Detection of occult gastrinomas with iodine 125-labeled lanreotide and intraoperative gamma detection. 1994 Dec 1
19 8234912 Morphometry of gastric endocrine cells in hypergastrinemic patients treated with the somatostatin analogue octreotide. 1993 Sep 22 1
20 8325938 Octreotide long term treatment of acromegaly: effect of drug withdrawal on serum growth hormone/insulin-like growth factor-I concentrations and on serum gastrin/24-hour intragastric pH values. 1993 Jul 4
21 8359571 Somatostatin analogue therapy in functioning neuroendocrine gut tumors. 1993 1
22 8406151 Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man. 1993 Sep 1
23 1355350 Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide. 1992 3
24 1360710 Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas. 1992 Dec 2
25 1487608 A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. 1992 Nov 1
26 1514904 Long-term efficacy of octreotide in the treatment of Zollinger-Ellison syndrome. 1992 Sep 5
27 1802924 Patterns of gastrin secretion in patients with nonfunctioning pituitary adenomas. 1991 Nov 1
28 2168430 Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. 1990 Sep 1
29 2171015 Effect of somatostatin analogue (octreotide) on blood flow to endocrine tumors metastatic to the liver: angiographic evaluation. 1990 Nov 1
30 2188384 Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome. 1990 Jun 1
31 2518866 Prolonged inhibition of meal-stimulated acid secretion and gastrin release following single subcutaneous administration of octreotide (SMS 201-995) in man. 1989 Dec 1
32 2879448 Characterization of the in vivo and in vitro inhibition of gastrin secretion from gastrinoma by a somatostatin analogue (SMS 201-995). 1986 Dec 22 1
33 2862099 Treatment of relapsing bleeding peptic ulcers with the somatostatin analogue SMS 201 995 in a patient with Zollinger-Ellison syndrome. 1985 Jun 1